Unique characteristics of informal hospice cancer caregiving
the ONA take:
According to a recent study published in the journal Supportive Care in Cancer, researchers from the University of Missouri in Columbia and University of Washington in Seattle have identified unique characteristics of informal caregivers of patients with cancer that will ultimately help hospice providers to better address cancer caregivers' needs.
For the study, researchers analyzed data from a randomized clinical trial that included 348 informal hospice caregivers and compared the differences between cancer and non-cancer caregivers.
Results showed that informal caregivers of patients with cancer differed from non-cancer caregivers in respect to caregiver age, patient age, patient residence, amount and duration of care provided, relationship between caregiver and patient, likelihood to incur out-of-pocket expenses related to caring for the patient, effect on caregiver daily schedule, and caregiver problem-solving approach.
On the other hand, researchers found no significant differences between cancer caregivers and their non-cancer counterparts in regard to anxiety, employment status, gender, race, and quality of life.
The authors note that hospice providers can use these findings to customize supportive care interventions to more effectively address the needs of cancer caregivers.
Unique characteristics of informal caregivers of patients with cancer that will ultimately help hospice providers.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses
- COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|